Czech/SlovakiaCzech RepublicSlovakia

Catching up on the biotech revolution


In order to keep track of developments and to promote network-creation, for both domestic-domestic and domestic-foreign cooperations the South Moravian Innovation Centre, Brno, has conducted the Czech Republic’s first comprehensive biotech survey which follows OECD recommendations. Its findings are presented in the Czech Biotech Report 2006. The report testifies that the Czech biotech sector is developing at a rapid pace. A long history of biotechnology research and development has secured the country a strong position in a number of technological areas, including industrial biotechnology and health care.

Experts from the South Moravian Innovation Centre have identified 120 biotechnology companies in the Czech Republic. In line with current OECD recommendations, 55 companies, predominantly from traditional food, beverages and brewing industries, were omitted from the survey. From the remaining 65 biotechnology companies, 20 were identified as ‘dedicated’ Czech biotechnology firms, 11 as subsidiaries of foreign dedicated biotech firms and 34 as so-called innovative biotech firms (biotech business units of otherwisely diversified companies). Besides private enterprises and corporations, the report names 220 universities and biotechnology research institutes in the country.
The authors see the Czech Republic’s biggest advantage in its tight academic network of universities and research in stitutes that is spread accross the whole country, instead of being mainly concentrated around the capital region of Prague. In 2005, according to the report, 56,777 students were enrolled on life science courses at universities, with an output of 7,400 graduates annually.
Development of distinct clusters
Prague is, and always has been, a centre for

research and development, and the capital region maintains its attraction as a strong

biotech location. Prague and Central Bohemia are home to 4 in 10 of the biotech companies and to almost half of all universities and biotech research institutes.
Another important cluster is forming around the city of Brno in Southern Moravia, which has a strong tradition in medical research, particularly with cancer and cardiovascular diseases. Brno enjoys an excellent infrastructure, a strong academic network and encourangement from the local government. It is home to roughly one-fifth of the companies and research institutes identified in the report.
Broad expertise
The survey of the companies’ and research institutes’ ‘biotechnology techniques’ and ‘biotechnology applications’ points to a very broad expertise within the Czech biotech community, and accross all disciplines. Still, companies concentrate their activities in the sectors of environment (83%), microbial and cell biotechnology (81%) and human/veterinary diagnostics (63%). The three sectors in which Czech research institutes are most active in are plant biotechnology (96%), microbial and cell biotechnology (40%) and animal biotechnology (39%).
South Moravian Innovation Centre – JIC
U Vodárny 2, 616 00 Brno, Czech Republic
Tel./Fax: +420-541-1430-00 /-11,

Czech/SlovakiaCzech RepublicSlovakia


Prague – After increasing its investment in mid-January, full-service provider CRO FGK Clinical Research GmbH has become a major shareholder in the Czech contract research organization Avemedica s.r.o. Financial details were not...

Czech/SlovakiaCzech RepublicSlovakia


Pilzen – German antibody drug development and discovery firm Affimed Therapeutics AG (Heidelberg) has spun-out all of its antibody discovery activities into a new Czech subsidiary – AbCheck s.r.o., which is located in Pilzen....

Czech/SlovakiaCzech RepublicSlovakia


Prague/Jena – German and Czech researchers under Ales Svatos have opened the door to major improvements in the application of high-throughput metabolomics and systematic analyses of small molecules via MALDI-mass spectrometry...

Czech/SlovakiaCzech RepublicSlovakia


Ceské Budejovice - The scientists from the Biology Centre of the Czech Academy of Science who coordinated the EU project MOBITAG have tabled a report on their attitudes towards political interference in the EU’s GMO authorisation...

Czech/SlovakiaCzech RepublicSlovakia


Bratislava – According to a new study released by PG Economics, Slovak farmers would benefit more than counterparts in other EU countries from planting genetically-engineered Bt maize. Regional factors, as well as reducing an...

Czech/SlovakiaCzech RepublicSlovakia


Vestec – The Czech Academy of Sciences and Charles University plan to build a modern biotechnology and biomedicine center, according to reports issued by the Czech Information Agency. With about 40,000 square meters of floor...

Czech/SlovakiaCzech RepublicSlovakia


Olomouc – A new cluster with a focus on drug development and diagnostics has been established near Palacky University in Olmouc. Called MedChemBio, the centre seeks to attract companies with an interest in medicinal and...

Czech/SlovakiaCzech RepublicSlovakia


Prague – A biotech company and a pharmaceutical enterprise are the winners of this year’s “Investor of the Year” competition, which is organised by CzechInvest and the country’s Association for Foreign Investment. At the end of...

Czech/SlovakiaCzech RepublicSlovakia


Prague – A2Z Bio, the Czech subsidiary of UK-based Yorkshire Bioscience, is investing EUR100,000 at the CKD Prague Technological Innovation Centre to launch production of research reagents and services for the biotech R&D market....

Displaying results 11 to 20 out of 70

< Previous 11-20 Next >

© 2007-2015 BIOCOM


LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Product of the week


Job Advert

Sales Manager

celares GmbH is a Berlin based drug delivery company focused on chemical modifications of biological drugs. We offer customized development services for international pharma and biopharma companies and have manufacturing capabilities for key starting materials used for the preparation of pharmaceutical drugs. For the intensification of our own sales activities we are looking for a sales manager. more...


All Events



BioVaria 2015

Stock list

All quotes


  • THERAMETRICS0.08 CHF14.29%
  • MEDIGENE10.96 EUR4.88%
  • EVOLVA1.58 CHF3.27%


  • BIOTEST71.00 EUR-3.92%
  • SYNGENTA314.40 CHF-3.65%
  • 4SC5.03 EUR-3.27%


  • 4SC5.03 EUR293.0%
  • WILEX4.33 EUR51.4%
  • SARTORIUS151.00 EUR21.2%


  • CYTOS1.01 CHF-29.4%
  • BIOTEST71.00 EUR-26.9%
  • BIOFRONTERA2.30 EUR-11.2%


  • SANTHERA96.45 CHF2329.5%
  • CYTOS1.01 CHF676.9%
  • WILEX4.33 EUR397.7%


  • MOLOGEN4.94 EUR-55.4%
  • BIOFRONTERA2.30 EUR-29.2%
  • BIOTEST71.00 EUR-20.0%

No liability assumed, Date: 02.05.2015

Current issue

All issues